Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL’ Campaign

• ‘Highlights REAL’ aims to spark vital conversations about advanced prostate cancer and educate about the importance of treatment management

WHIPPANY, N.J.–(BUSINESS WIRE)–Today Bayer announced it has teamed up with former professional quarterback, Tony Romo, on ‘Highlights REAL,’ a campaign celebrating everyday moments. Tony is joined by his father Ramiro, who has personally faced prostate cancer, to provide play-by-play commentary, not on football, but of advanced prostate cancer patients and their caregivers, fostering a deeper appreciation for everyday moments, both big and small.

This campaign also aims to ignite vital conversations about prostate cancer, the leading cancer diagnosis among men, by empowering patients and their families to take an active role in their health.¹ It underscores the importance of patients and caregivers having a game plan in place when discussing management strategies and treatment options, like NUBEQA^®, with their doctor. NUBEQA is indicated in the U.S. for the treatment of adult patients with metastatic castration-sensitive prostate cancer (mCSPC), both with and without docetaxel, and for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC).²

“Partnering with Bayer has allowed me to step off the football field and engage in some of the most meaningful work of my career – spotlighting the everyday experiences of some patients with advanced prostate cancer,” said Tony Romo. “I hope this campaign inspires others to appreciate the small, meaningful moments in life and to take proactive steps when it comes to prostate cancer screening and treatment management. Having witnessed my dad navigate his own journey with prostate cancer, I’ve come to deeply appreciate the importance of being vigilant and informed about your options.”

Through ‘Highlights REAL’ Tony Romo and Bayer are encouraging patients with advanced prostate cancer and their caregivers to talk to their doctor and discuss if NUBEQA could be right for them.

“We’re excited to shine a light on NUBEQA patients’ cherished moments that often get overlooked while navigating the demands of advanced prostate cancer and encourage wider conversations on the disease and treatment management with the ‘Highlights REAL’ campaign,” said Nicole Dinello, VP Prostate Marketing at Bayer. “Thank you, Tony, Ramiro and all our NUBEQA patients and caregivers for candidly sharing your stories and encouraging others to reflect on their own personal ‘highlights.’”

To watch the ‘Highlights REAL’ video, learn more about the campaign and find support for navigating discussions about advanced prostate cancer treatment with your doctor, visit HighlightsREAL.com.

Tony and Ramiro Romo have been compensated for their participation and are not NUBEQA patients.

What is NUBEQA^® (darolutamide)²
NUBEQA^® (darolutamide) is a prescription medicine used to treat adults with prostate cancer:

• that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone
• that has spread to other parts of the body and responds to a medical or surgical treatment that lowers testosterone
• that has spread to other parts of the body and responds to a medical or surgical treatment that lowers testosterone in combination with docetaxel.
• It is not known if NUBEQA is safe and effective in females or children.

IMPORTANT SAFETY INFORMATION

Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:

• have heart problems, high blood pressure, diabetes, or high amounts of fat or cholesterol in your blood (dyslipidemia)
• have a history of seizures, brain injury, stroke, or brain tumors
• have kidney or liver problems
• are pregnant or plan to become pregnant. NUBEQA can cause harm to your unborn baby and loss of pregnancy (miscarriage)
• have a partner who may become pregnant. Males who have female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA. Talk with your healthcare provider about birth control methods
• are breastfeeding or plan to breastfeed. It is not known if NUBEQA passes into breast milk

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.

You should not start or stop any medicine before you talk with the healthcare provider that prescribed NUBEQA.

Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.

NUBEQA may cause serious side effects, including:

• Heart disease. Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with NUBEQA. Your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with NUBEQA. Call your healthcare provider or get medical help right away if you get chest pain or discomfort at rest or with activity, or shortness of breath during your treatment with NUBEQA.
• Seizure. Treatment with NUBEQA may increase your risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure during treatment with NUBEQA.

The most common side effects of NUBEQA include:

• increase in liver function tests
• decreased white blood cells (neutropenia)
• feeling more tired than usual

The most common side effects of NUBEQA in combination with docetaxel include:

• constipation
• rash
• decreased appetite
• bleeding
• weight gain
• high blood pressure
• decreased red blood cells (anemia)
• high blood sugar levels
• decreased white blood cells
• increase in liver function tests
• low blood calcium levels

NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of NUBEQA.

Call your healthcare provider for medical advice about side effects. You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.

Please see the full Prescribing Information.

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to www.bayer.com.

^© 2026 Bayer
BAYER, the Bayer Cross and NUBEQA are registered trademarks of Bayer.

Find more information at www.pharma.bayer.com
Our online press service is just a click away: www.bayer.us/en/newsroom
Follow us on Facebook: http://www.facebook.com/pharma.bayer
Follow us on X: https://X.com/BayerUS

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

References

1. Cancer Stat Facts – Common Cancer Sites. National Cancer Institute. https://seer.cancer.gov/statfacts/html/common.html. December 2025.
2. NUBEQA^® (darolutamide) [Prescribing Information]. Whippany, NJ: Bayer HealthCare Pharmaceuticals, Inc.; June 2025.

Contacts

Media Contact:
Polina Miklush, Tel +1 862.431.8817
Email: polina.miklush@bayer.com